PAP

Persistent Asset Partners Portfolio holdings

AUM $138M
1-Year Est. Return 38.77%
This Quarter Est. Return
1 Year Est. Return
+38.77%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$138M
AUM Growth
+$23.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
264
New
Increased
Reduced
Closed

Top Buys

1
+$8.19M
2
+$4.82M
3
+$4.17M
4
CVS icon
CVS Health
CVS
+$3.89M
5
NBIS
Nebius Group N.V.
NBIS
+$3.37M

Top Sells

1
+$4.91M
2
+$3.58M
3
+$3.43M
4
AMGN icon
Amgen
AMGN
+$3.35M
5
LLY icon
Eli Lilly
LLY
+$2.65M

Sector Composition

1 Healthcare 51.53%
2 Financials 14.56%
3 Technology 6.97%
4 Consumer Discretionary 6.12%
5 Materials 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRMY icon
101
Harmony Biosciences
HRMY
$2.09B
$317K 0.22%
+11,500
OSBC icon
102
Old Second Bancorp
OSBC
$1.09B
$314K 0.22%
+18,182
AMLX icon
103
Amylyx Pharmaceuticals
AMLX
$1.57B
$311K 0.21%
+22,913
DNN icon
104
Denison Mines
DNN
$3.31B
$310K 0.21%
+112,549
SCI icon
105
Service Corp International
SCI
$11.6B
$307K 0.21%
+3,688
RNA icon
106
Avidity Biosciences
RNA
$10.9B
$299K 0.21%
+6,864
DFTX
107
Definium Therapeutics, Inc. Common Shares
DFTX
$1.48B
$286K 0.2%
24,282
-12,360
LNKB icon
108
LINKBANCORP
LNKB
$325M
$284K 0.19%
+39,782
SMBK icon
109
SmartFinancial
SMBK
$671M
$267K 0.18%
7,485
-12,151
VTGN icon
110
VistaGen Therapeutics
VTGN
$26.2M
$267K 0.18%
75,319
-11,500
ADUS icon
111
Addus HomeCare
ADUS
$1.99B
$267K 0.18%
+2,259
MNKD icon
112
MannKind Corp
MNKD
$1.6B
$265K 0.18%
+49,262
SLSR
113
Solaris Resources
SLSR
$1.47B
$259K 0.18%
40,656
SUPN icon
114
Supernus Pharmaceuticals
SUPN
$2.87B
$247K 0.17%
+5,159
NRG icon
115
NRG Energy
NRG
$29.1B
$246K 0.17%
+1,520
HCC icon
116
Warrior Met Coal
HCC
$5.26B
$236K 0.16%
3,716
-12,483
CPRX icon
117
Catalyst Pharmaceutical
CPRX
$2.79B
$225K 0.15%
+11,441
RVPH icon
118
Reviva Pharmaceuticals
RVPH
$42M
$219K 0.15%
593,902
-47,272
SGRY icon
119
Surgery Partners
SGRY
$2.06B
$210K 0.14%
+9,704
ARCT icon
120
Arcturus Therapeutics
ARCT
$207M
$206K 0.14%
+11,189
TRVI icon
121
Trevi Therapeutics
TRVI
$1.34B
$180K 0.12%
19,688
-23,100
NKE icon
122
Nike
NKE
$95.3B
$162K 0.11%
+2,325
FSLR icon
123
First Solar
FSLR
$26.2B
$154K 0.11%
+700
XERS icon
124
Xeris Biopharma Holdings
XERS
$1.25B
$140K 0.1%
+17,202
CTMX icon
125
CytomX Therapeutics
CTMX
$913M
$136K 0.09%
+42,645
3 4
5
6 7